πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 635 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10836744

Diamide compounds having muscarinic receptor antagonist and Ξ²2 adrenergic receptor agonist

Theravance Respiratory Company, LLC Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10836763

5 to 7 membered heterocyclic amides as JAK inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10829438

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10774080

Pyrimidine compound as JAK kinase inhibitor

Theravance Biopharma R&D IP, LLC Β· Granted Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10759813

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10752599

Crystalline (2S,4R)-5-(5β€²-chloro-2β€²-fluoro-[1,1β€²-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hyd

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10744104

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10745405

Glucuronide prodrugs of Janus kinase inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10745394

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance Biopharma R&D IP, LLC Β· Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10722504

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10696656

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10590107

Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agon

Theravance Respiratory Company, LLC Β· Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10577347

Crystalline forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10576073

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

Theravance Biopharma R&D IP, LLC Β· Granted Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570120

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10570092

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562894

Pyrimidine compound as JAK kinase inhibitor

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550118

JAK inhibitors containing a 4-membered heterocyclic amide

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548879

(2R,4R)-5-(5β€²-chloro-2β€²-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amin

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10550081

Crystalline freebase forms of a biphenyl compound

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10548886

Methods of treatment using a JAK inhibitor compound

Theravance Biopharma R&D IP, LLC Β· Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10538513

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10526330

JAK kinase inhibitor compounds for treatment of respiratory disease

Theravance Biopharma R&D IP, LLC Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10519153

Fused imidazo-piperidine JAK inhibitors

Theravance Biopharma R&D IP, LLC Β· Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted